Clinical Implications of Dietary Probiotic Supplement (Associated with L-Glutamine and Biotin) in Ulcerative Colitis Patients' Body Composition and Quality of Life

Patients with ulcerative colitis (UC) are reported to have changes in body structure, with negative impact on the course of disease. This study explored the effects of a standardized nutritional supplement containing five bacterial strains of at least five billion bacteria ( , , , , and , L-glutamin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrients 2023-12, Vol.15 (24), p.5049
Hauptverfasser: Pavel, Flavia Maria, Bungau, Simona Gabriela, Tit, Delia Mirela, Ghitea, Timea Claudia, Marin, Ruxandra Cristina, Radu, Andrei-Flavius, Moleriu, Radu Dumitru, Ilias, Tiberia, Bustea, Cristian, Vesa, Cosmin Mihai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 24
container_start_page 5049
container_title Nutrients
container_volume 15
creator Pavel, Flavia Maria
Bungau, Simona Gabriela
Tit, Delia Mirela
Ghitea, Timea Claudia
Marin, Ruxandra Cristina
Radu, Andrei-Flavius
Moleriu, Radu Dumitru
Ilias, Tiberia
Bustea, Cristian
Vesa, Cosmin Mihai
description Patients with ulcerative colitis (UC) are reported to have changes in body structure, with negative impact on the course of disease. This study explored the effects of a standardized nutritional supplement containing five bacterial strains of at least five billion bacteria ( , , , , and , L-glutamine, and biotin on the body composition and quality of life of patients with UC. Ninety-three patients over 18 years of age with a confirmed diagnosis of UC, for whom body composition could be accurately determined, were included in this observational follow-up randomized study. These patients were split into two groups: UC-P (44 patients with dietary counselling and supplement with probiotics) and UC-NP (49 patients with dietary counselling, without supplement). Body composition was assessed using the multifrequency bioelectrical impedance device, and the quality of life related to UC was evaluated by applying the short inflammatory bowel disease questionnaire (SIBDQ). The results showed that the average value of muscular mass (MM) and sarcopenic index (SMI) significantly increased ( = 0.043, respectively, = 0.001) and a large fraction ( = 0.001) of patients had their SMI levels normalized in the UC-P group compared with UC-NP group. The extracellular water to total body water ratio (ECW/TBW) also had significantly different mean values ( = 0.022), favoring the UC-P group. By testing the differences between the average values of body composition parameters before and after treatment, we obtained significant results in body mass index (BMI) ( = 0.046), fat free mass (FFM) ( < 0.001), and ECW/TBW ratio ( = 0.048). The SIBDQ total score increased significantly ( < 0.001) in the UC-P group and was more strongly associated with changes in body parameters. Supplementation with probiotics associated with L-glutamine and biotin can improve body composition parameters, which in turn implies an increase in the overall quality of life of patients with UC.
doi_str_mv 10.3390/nu15245049
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2905526332</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A779214198</galeid><sourcerecordid>A779214198</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-fd6d9e8901779f1e435bfa70f00311fd8d7f52d7c773623bcb322fd3a9421eb3</originalsourceid><addsrcrecordid>eNptks1u1TAQhSMEolXphgdAllhQkFL8k8TJ8vYCpdKVKKKsI8cew1SOHWIHdJ-HF8WhhQLCXng8-s7xkTxF8ZjRUyE6-tIvrOZVTavuXnHIqeRl01Ti_h_1QXEc4zVdl6SyEQ-LA9GyigraHhbftw49auXIxTi5XCQMPpJgySuEpOY9uZzDgCGhJh-WaXIwgk_kZBNj0KgSGPIN02eyK8_dktSIHojyhpytEv-coCcfnYY5-34Fsg0OE0Zyma_ZJj4jZ8Hsc3ucQsT16Z_i94vK3H5NsUMLj4oHVrkIx7fnUXH15vXV9m25e3d-sd3sSl2xNpXWNKaDtqNMys4yqEQ9WCWppVQwZk1rpK25kVpK0XAx6EFwbo1QXcUZDOKoOLmxnebwZYGY-hGjBueUh7DEnne0rnkjBM_o03_Q67DMPodbqUrKltLmjvqkHPTobUiz0qtpv8kROatY12bq9D9U3gZG1MGDxdz_S_DiRqDnEOMMtp9mHPNX9Yz260z0dzOR4Se3SZdhBPMb_TUB4gdvT7Cs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2904778006</pqid></control><display><type>article</type><title>Clinical Implications of Dietary Probiotic Supplement (Associated with L-Glutamine and Biotin) in Ulcerative Colitis Patients' Body Composition and Quality of Life</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Pavel, Flavia Maria ; Bungau, Simona Gabriela ; Tit, Delia Mirela ; Ghitea, Timea Claudia ; Marin, Ruxandra Cristina ; Radu, Andrei-Flavius ; Moleriu, Radu Dumitru ; Ilias, Tiberia ; Bustea, Cristian ; Vesa, Cosmin Mihai</creator><creatorcontrib>Pavel, Flavia Maria ; Bungau, Simona Gabriela ; Tit, Delia Mirela ; Ghitea, Timea Claudia ; Marin, Ruxandra Cristina ; Radu, Andrei-Flavius ; Moleriu, Radu Dumitru ; Ilias, Tiberia ; Bustea, Cristian ; Vesa, Cosmin Mihai</creatorcontrib><description>Patients with ulcerative colitis (UC) are reported to have changes in body structure, with negative impact on the course of disease. This study explored the effects of a standardized nutritional supplement containing five bacterial strains of at least five billion bacteria ( , , , , and , L-glutamine, and biotin on the body composition and quality of life of patients with UC. Ninety-three patients over 18 years of age with a confirmed diagnosis of UC, for whom body composition could be accurately determined, were included in this observational follow-up randomized study. These patients were split into two groups: UC-P (44 patients with dietary counselling and supplement with probiotics) and UC-NP (49 patients with dietary counselling, without supplement). Body composition was assessed using the multifrequency bioelectrical impedance device, and the quality of life related to UC was evaluated by applying the short inflammatory bowel disease questionnaire (SIBDQ). The results showed that the average value of muscular mass (MM) and sarcopenic index (SMI) significantly increased ( = 0.043, respectively, = 0.001) and a large fraction ( = 0.001) of patients had their SMI levels normalized in the UC-P group compared with UC-NP group. The extracellular water to total body water ratio (ECW/TBW) also had significantly different mean values ( = 0.022), favoring the UC-P group. By testing the differences between the average values of body composition parameters before and after treatment, we obtained significant results in body mass index (BMI) ( = 0.046), fat free mass (FFM) ( &lt; 0.001), and ECW/TBW ratio ( = 0.048). The SIBDQ total score increased significantly ( &lt; 0.001) in the UC-P group and was more strongly associated with changes in body parameters. Supplementation with probiotics associated with L-glutamine and biotin can improve body composition parameters, which in turn implies an increase in the overall quality of life of patients with UC.</description><identifier>ISSN: 2072-6643</identifier><identifier>EISSN: 2072-6643</identifier><identifier>DOI: 10.3390/nu15245049</identifier><identifier>PMID: 38140308</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adolescent ; Adult ; Biotin ; Biotin - therapeutic use ; Body Composition ; Colitis, Ulcerative - drug therapy ; Diet therapy ; Dietary Supplements ; Endoscopy ; Evolution ; Fatty acids ; Glutamine ; Glutamine - therapeutic use ; Humans ; Immunology ; Inflammation ; Inflammatory bowel disease ; Inflammatory Bowel Diseases - complications ; Magnetic resonance imaging ; Malnutrition ; Medical research ; Medicine, Experimental ; Nutritional status ; Patients ; Physiological aspects ; Probiotics ; Probiotics - therapeutic use ; Quality of Life ; Remission (Medicine) ; Ulcerative colitis ; Variables</subject><ispartof>Nutrients, 2023-12, Vol.15 (24), p.5049</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-fd6d9e8901779f1e435bfa70f00311fd8d7f52d7c773623bcb322fd3a9421eb3</citedby><cites>FETCH-LOGICAL-c418t-fd6d9e8901779f1e435bfa70f00311fd8d7f52d7c773623bcb322fd3a9421eb3</cites><orcidid>0000-0003-3236-1292 ; 0000-0001-5071-9601 ; 0000-0002-0296-6592 ; 0000-0002-7625-8177 ; 0000-0001-8981-1958</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38140308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pavel, Flavia Maria</creatorcontrib><creatorcontrib>Bungau, Simona Gabriela</creatorcontrib><creatorcontrib>Tit, Delia Mirela</creatorcontrib><creatorcontrib>Ghitea, Timea Claudia</creatorcontrib><creatorcontrib>Marin, Ruxandra Cristina</creatorcontrib><creatorcontrib>Radu, Andrei-Flavius</creatorcontrib><creatorcontrib>Moleriu, Radu Dumitru</creatorcontrib><creatorcontrib>Ilias, Tiberia</creatorcontrib><creatorcontrib>Bustea, Cristian</creatorcontrib><creatorcontrib>Vesa, Cosmin Mihai</creatorcontrib><title>Clinical Implications of Dietary Probiotic Supplement (Associated with L-Glutamine and Biotin) in Ulcerative Colitis Patients' Body Composition and Quality of Life</title><title>Nutrients</title><addtitle>Nutrients</addtitle><description>Patients with ulcerative colitis (UC) are reported to have changes in body structure, with negative impact on the course of disease. This study explored the effects of a standardized nutritional supplement containing five bacterial strains of at least five billion bacteria ( , , , , and , L-glutamine, and biotin on the body composition and quality of life of patients with UC. Ninety-three patients over 18 years of age with a confirmed diagnosis of UC, for whom body composition could be accurately determined, were included in this observational follow-up randomized study. These patients were split into two groups: UC-P (44 patients with dietary counselling and supplement with probiotics) and UC-NP (49 patients with dietary counselling, without supplement). Body composition was assessed using the multifrequency bioelectrical impedance device, and the quality of life related to UC was evaluated by applying the short inflammatory bowel disease questionnaire (SIBDQ). The results showed that the average value of muscular mass (MM) and sarcopenic index (SMI) significantly increased ( = 0.043, respectively, = 0.001) and a large fraction ( = 0.001) of patients had their SMI levels normalized in the UC-P group compared with UC-NP group. The extracellular water to total body water ratio (ECW/TBW) also had significantly different mean values ( = 0.022), favoring the UC-P group. By testing the differences between the average values of body composition parameters before and after treatment, we obtained significant results in body mass index (BMI) ( = 0.046), fat free mass (FFM) ( &lt; 0.001), and ECW/TBW ratio ( = 0.048). The SIBDQ total score increased significantly ( &lt; 0.001) in the UC-P group and was more strongly associated with changes in body parameters. Supplementation with probiotics associated with L-glutamine and biotin can improve body composition parameters, which in turn implies an increase in the overall quality of life of patients with UC.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biotin</subject><subject>Biotin - therapeutic use</subject><subject>Body Composition</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Diet therapy</subject><subject>Dietary Supplements</subject><subject>Endoscopy</subject><subject>Evolution</subject><subject>Fatty acids</subject><subject>Glutamine</subject><subject>Glutamine - therapeutic use</subject><subject>Humans</subject><subject>Immunology</subject><subject>Inflammation</subject><subject>Inflammatory bowel disease</subject><subject>Inflammatory Bowel Diseases - complications</subject><subject>Magnetic resonance imaging</subject><subject>Malnutrition</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Nutritional status</subject><subject>Patients</subject><subject>Physiological aspects</subject><subject>Probiotics</subject><subject>Probiotics - therapeutic use</subject><subject>Quality of Life</subject><subject>Remission (Medicine)</subject><subject>Ulcerative colitis</subject><subject>Variables</subject><issn>2072-6643</issn><issn>2072-6643</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNptks1u1TAQhSMEolXphgdAllhQkFL8k8TJ8vYCpdKVKKKsI8cew1SOHWIHdJ-HF8WhhQLCXng8-s7xkTxF8ZjRUyE6-tIvrOZVTavuXnHIqeRl01Ti_h_1QXEc4zVdl6SyEQ-LA9GyigraHhbftw49auXIxTi5XCQMPpJgySuEpOY9uZzDgCGhJh-WaXIwgk_kZBNj0KgSGPIN02eyK8_dktSIHojyhpytEv-coCcfnYY5-34Fsg0OE0Zyma_ZJj4jZ8Hsc3ucQsT16Z_i94vK3H5NsUMLj4oHVrkIx7fnUXH15vXV9m25e3d-sd3sSl2xNpXWNKaDtqNMys4yqEQ9WCWppVQwZk1rpK25kVpK0XAx6EFwbo1QXcUZDOKoOLmxnebwZYGY-hGjBueUh7DEnne0rnkjBM_o03_Q67DMPodbqUrKltLmjvqkHPTobUiz0qtpv8kROatY12bq9D9U3gZG1MGDxdz_S_DiRqDnEOMMtp9mHPNX9Yz260z0dzOR4Se3SZdhBPMb_TUB4gdvT7Cs</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Pavel, Flavia Maria</creator><creator>Bungau, Simona Gabriela</creator><creator>Tit, Delia Mirela</creator><creator>Ghitea, Timea Claudia</creator><creator>Marin, Ruxandra Cristina</creator><creator>Radu, Andrei-Flavius</creator><creator>Moleriu, Radu Dumitru</creator><creator>Ilias, Tiberia</creator><creator>Bustea, Cristian</creator><creator>Vesa, Cosmin Mihai</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3236-1292</orcidid><orcidid>https://orcid.org/0000-0001-5071-9601</orcidid><orcidid>https://orcid.org/0000-0002-0296-6592</orcidid><orcidid>https://orcid.org/0000-0002-7625-8177</orcidid><orcidid>https://orcid.org/0000-0001-8981-1958</orcidid></search><sort><creationdate>20231201</creationdate><title>Clinical Implications of Dietary Probiotic Supplement (Associated with L-Glutamine and Biotin) in Ulcerative Colitis Patients' Body Composition and Quality of Life</title><author>Pavel, Flavia Maria ; Bungau, Simona Gabriela ; Tit, Delia Mirela ; Ghitea, Timea Claudia ; Marin, Ruxandra Cristina ; Radu, Andrei-Flavius ; Moleriu, Radu Dumitru ; Ilias, Tiberia ; Bustea, Cristian ; Vesa, Cosmin Mihai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-fd6d9e8901779f1e435bfa70f00311fd8d7f52d7c773623bcb322fd3a9421eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biotin</topic><topic>Biotin - therapeutic use</topic><topic>Body Composition</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Diet therapy</topic><topic>Dietary Supplements</topic><topic>Endoscopy</topic><topic>Evolution</topic><topic>Fatty acids</topic><topic>Glutamine</topic><topic>Glutamine - therapeutic use</topic><topic>Humans</topic><topic>Immunology</topic><topic>Inflammation</topic><topic>Inflammatory bowel disease</topic><topic>Inflammatory Bowel Diseases - complications</topic><topic>Magnetic resonance imaging</topic><topic>Malnutrition</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Nutritional status</topic><topic>Patients</topic><topic>Physiological aspects</topic><topic>Probiotics</topic><topic>Probiotics - therapeutic use</topic><topic>Quality of Life</topic><topic>Remission (Medicine)</topic><topic>Ulcerative colitis</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pavel, Flavia Maria</creatorcontrib><creatorcontrib>Bungau, Simona Gabriela</creatorcontrib><creatorcontrib>Tit, Delia Mirela</creatorcontrib><creatorcontrib>Ghitea, Timea Claudia</creatorcontrib><creatorcontrib>Marin, Ruxandra Cristina</creatorcontrib><creatorcontrib>Radu, Andrei-Flavius</creatorcontrib><creatorcontrib>Moleriu, Radu Dumitru</creatorcontrib><creatorcontrib>Ilias, Tiberia</creatorcontrib><creatorcontrib>Bustea, Cristian</creatorcontrib><creatorcontrib>Vesa, Cosmin Mihai</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Nutrients</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pavel, Flavia Maria</au><au>Bungau, Simona Gabriela</au><au>Tit, Delia Mirela</au><au>Ghitea, Timea Claudia</au><au>Marin, Ruxandra Cristina</au><au>Radu, Andrei-Flavius</au><au>Moleriu, Radu Dumitru</au><au>Ilias, Tiberia</au><au>Bustea, Cristian</au><au>Vesa, Cosmin Mihai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Implications of Dietary Probiotic Supplement (Associated with L-Glutamine and Biotin) in Ulcerative Colitis Patients' Body Composition and Quality of Life</atitle><jtitle>Nutrients</jtitle><addtitle>Nutrients</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>15</volume><issue>24</issue><spage>5049</spage><pages>5049-</pages><issn>2072-6643</issn><eissn>2072-6643</eissn><abstract>Patients with ulcerative colitis (UC) are reported to have changes in body structure, with negative impact on the course of disease. This study explored the effects of a standardized nutritional supplement containing five bacterial strains of at least five billion bacteria ( , , , , and , L-glutamine, and biotin on the body composition and quality of life of patients with UC. Ninety-three patients over 18 years of age with a confirmed diagnosis of UC, for whom body composition could be accurately determined, were included in this observational follow-up randomized study. These patients were split into two groups: UC-P (44 patients with dietary counselling and supplement with probiotics) and UC-NP (49 patients with dietary counselling, without supplement). Body composition was assessed using the multifrequency bioelectrical impedance device, and the quality of life related to UC was evaluated by applying the short inflammatory bowel disease questionnaire (SIBDQ). The results showed that the average value of muscular mass (MM) and sarcopenic index (SMI) significantly increased ( = 0.043, respectively, = 0.001) and a large fraction ( = 0.001) of patients had their SMI levels normalized in the UC-P group compared with UC-NP group. The extracellular water to total body water ratio (ECW/TBW) also had significantly different mean values ( = 0.022), favoring the UC-P group. By testing the differences between the average values of body composition parameters before and after treatment, we obtained significant results in body mass index (BMI) ( = 0.046), fat free mass (FFM) ( &lt; 0.001), and ECW/TBW ratio ( = 0.048). The SIBDQ total score increased significantly ( &lt; 0.001) in the UC-P group and was more strongly associated with changes in body parameters. Supplementation with probiotics associated with L-glutamine and biotin can improve body composition parameters, which in turn implies an increase in the overall quality of life of patients with UC.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38140308</pmid><doi>10.3390/nu15245049</doi><orcidid>https://orcid.org/0000-0003-3236-1292</orcidid><orcidid>https://orcid.org/0000-0001-5071-9601</orcidid><orcidid>https://orcid.org/0000-0002-0296-6592</orcidid><orcidid>https://orcid.org/0000-0002-7625-8177</orcidid><orcidid>https://orcid.org/0000-0001-8981-1958</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6643
ispartof Nutrients, 2023-12, Vol.15 (24), p.5049
issn 2072-6643
2072-6643
language eng
recordid cdi_proquest_miscellaneous_2905526332
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Adolescent
Adult
Biotin
Biotin - therapeutic use
Body Composition
Colitis, Ulcerative - drug therapy
Diet therapy
Dietary Supplements
Endoscopy
Evolution
Fatty acids
Glutamine
Glutamine - therapeutic use
Humans
Immunology
Inflammation
Inflammatory bowel disease
Inflammatory Bowel Diseases - complications
Magnetic resonance imaging
Malnutrition
Medical research
Medicine, Experimental
Nutritional status
Patients
Physiological aspects
Probiotics
Probiotics - therapeutic use
Quality of Life
Remission (Medicine)
Ulcerative colitis
Variables
title Clinical Implications of Dietary Probiotic Supplement (Associated with L-Glutamine and Biotin) in Ulcerative Colitis Patients' Body Composition and Quality of Life
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T00%3A39%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Implications%20of%20Dietary%20Probiotic%20Supplement%20(Associated%20with%20L-Glutamine%20and%20Biotin)%20in%20Ulcerative%20Colitis%20Patients'%20Body%20Composition%20and%20Quality%20of%20Life&rft.jtitle=Nutrients&rft.au=Pavel,%20Flavia%20Maria&rft.date=2023-12-01&rft.volume=15&rft.issue=24&rft.spage=5049&rft.pages=5049-&rft.issn=2072-6643&rft.eissn=2072-6643&rft_id=info:doi/10.3390/nu15245049&rft_dat=%3Cgale_proqu%3EA779214198%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2904778006&rft_id=info:pmid/38140308&rft_galeid=A779214198&rfr_iscdi=true